JP2000201675A - Heat-resistant creatine amidinohydrolase and its production - Google Patents

Heat-resistant creatine amidinohydrolase and its production

Info

Publication number
JP2000201675A
JP2000201675A JP11033359A JP3335999A JP2000201675A JP 2000201675 A JP2000201675 A JP 2000201675A JP 11033359 A JP11033359 A JP 11033359A JP 3335999 A JP3335999 A JP 3335999A JP 2000201675 A JP2000201675 A JP 2000201675A
Authority
JP
Japan
Prior art keywords
creatine
enzyme
creatine amidinohydrolase
resistant
amidinohydrolase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP11033359A
Other languages
Japanese (ja)
Other versions
JP3773160B2 (en
Inventor
Keisuke Furukawa
圭介 古川
Taiji Koyama
泰二 小山
Masaru Suzuki
勝 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kikkoman Corp
Original Assignee
Kikkoman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kikkoman Corp filed Critical Kikkoman Corp
Priority to JP03335999A priority Critical patent/JP3773160B2/en
Priority to US09/869,280 priority patent/US6821766B1/en
Priority to EP99961487A priority patent/EP1142994B1/en
Priority to DE69936880T priority patent/DE69936880T2/en
Priority to PCT/JP1999/007424 priority patent/WO2000040708A1/en
Publication of JP2000201675A publication Critical patent/JP2000201675A/en
Application granted granted Critical
Publication of JP3773160B2 publication Critical patent/JP3773160B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/78Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y305/00Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/03Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amidines (3.5.3)
    • C12Y305/03003Creatinase (3.5.3.3), i.e. creatine amidinohydrolase

Abstract

PROBLEM TO BE SOLVED: To obtain the subject new heat-resistant enzyme having such catalytic activity as to hydrolyze creatine to form sarcosine and urea, therefore to be used for determining the creatine levels in human body fluids and useful as e.g. a diagnostic for various diseases including nephropathy. SOLUTION: This enzyme, a new heat-resistant creatine amidinohydrolase, has the following physicochemical characteristics: having such a catalytic activity as to hydrolyze 1 mol creatine to form 1 mol sarcosine and 1 mol urea; having substrate specificity to creatine, an optimum pH of 7.0-8.0, a stable pH range of 4.0-11.0, and a suitable action temperature of about 45 deg.C; stable at 53 deg.C; having a molecular weight of 92,000 (gel filtration method). Being capable of determining the creatine levels in human serum or urine, this enzyme is useful as e.g. a diagnostic for various diseases including nephropathy. This new enzyme is obtained by integrating Escherichia coli with a recombinant plasmid containing Alcaligenes sp. KS-85 strain-derived creatine amidinohydrolase gene which is then expressed.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、耐熱性クレアチン
アミジノハイドロラーゼ及びその製造法に関する。
The present invention relates to a thermostable creatine amidinohydrolase and a method for producing the same.

【0002】[0002]

【従来の技術】クレアチンアミジノハイドロラーゼは、
クレアチンを加水分解してザルコシン及び尿素を生成す
る触媒作用を有する酵素であり、ヒトの血清中又は尿中
のクレアチン量の測定に用いることができ、腎臓病をは
じめとする各種の疾患の診断薬として利用することがで
きる。従来、アルカリゲネス属由来のクレアチンアミジ
ノハイドロラーゼは、Km値がおおよそ13mMであ
り、また、耐熱性が45℃程度であるため、より低いK
m値を示し、しかも、将来における試薬の液状化での流
通、販売を考慮し、より高い温度に対し安定なクレアチ
ンアミジノハイドロラーゼが求められていた。更に、従
来、遺伝子改変により、クレアチンアミジノハイドロラ
ーゼの耐熱化を行なった場合、Km値が原株と同等か、
更に悪化してしまうことが多く、改変により耐熱性及び
Km値が向上したものは存在しなかった。
BACKGROUND OF THE INVENTION Creatine amidinohydrolase is
An enzyme that has the catalytic activity of hydrolyzing creatine to produce sarcosine and urea, can be used to measure the amount of creatine in human serum or urine, and is a diagnostic agent for various diseases including kidney disease Can be used as Conventionally, creatine amidinohydrolase derived from the genus Alcaligenes has a Km value of about 13 mM and a heat resistance of about 45 ° C., so that a lower K
A creatine amidinohydrolase that exhibits an m value and that is stable against higher temperatures has been demanded in consideration of the future distribution and sale of reagents in liquefaction. Furthermore, conventionally, when the heat resistance of creatine amidinohydrolase was performed by genetic modification, the Km value was the same as that of the original strain,
In many cases, the heat resistance and the Km value were improved by modification.

【0003】[0003]

【発明が解決しようとする課題】本発明は、耐熱性クレ
アチンアミジノハイドロラーゼ及びその製造法を提供す
ることを目的とするものである。
An object of the present invention is to provide a thermostable creatine amidinohydrolase and a method for producing the same.

【0004】[0004]

【課題を解決するための手段】本発明者等は、上記目的
に鑑み更に検討し、アルカリゲネス由来のクレアチンア
ミジノハイドラーゼ遺伝子(特開平8−89255号公
報記載)の遺伝子改変を行なった結果、耐熱性クレアチ
ンアミジノハイドラーゼが得られること等を見出し、本
発明を完成した。
Means for Solving the Problems The present inventors have further studied in view of the above-mentioned object, and as a result of genetically modifying the creatine amidinohydrolase gene derived from alkaligenes (described in JP-A-8-89255), The present inventors have found that sex creatine amidinohydrolase can be obtained, and have completed the present invention.

【0005】即ち、本発明は、下記の理化学的性質を有
する耐熱性クレアチンアミジノハイドロラーゼであり、 (a)作用;1モルのクレアチンを加水分解し、1モル
のザルコシン及び1モルの尿素を生成する。 (b)基質特異性;クレアチンに基質特異性を有する。 (c)至適pH;7.0〜8.0 (d)安定pH範囲;4.0〜11.0 (e)作用適温の範囲;45℃付近 (f)熱安定性;53℃ (g)分子量;92,000(ゲル濾過法) また、本発明は、前記の理化学的性質を有する耐熱性ク
レアチンアミジノハイドロラーゼ生産能を有する微生物
を培養し、その培養物から耐熱性クレアチンアミジノハ
イドロラーゼを採取することを特徴とする耐熱性クレア
チンアミジノハイドロラーゼの製造法である。
That is, the present invention is a thermostable creatine amidinohydrolase having the following physicochemical properties: (a) action: hydrolyzing one mole of creatine to produce one mole of sarcosine and one mole of urea; I do. (B) substrate specificity; creatine has substrate specificity. (C) optimum pH; 7.0 to 8.0 (d) stable pH range; 4.0 to 11.0 (e) range of suitable temperature for operation; around 45 ° C (f) thermal stability; 53 ° C (g ) Molecular weight: 92,000 (gel filtration method) In addition, the present invention comprises culturing a microorganism having the above-mentioned physicochemical properties and capable of producing heat-resistant creatine amidinohydrolase, and converting heat-resistant creatine amidinohydrolase from the culture. A method for producing thermostable creatine amidinohydrolase, which comprises collecting.

【0006】[0006]

【発明の実施の形態】以下、本発明を詳細に説明する。
本発明の耐熱性クレアチンアミジノハイドロラーゼは、
例えば、次のようにして得ることができる。先ず、単離
したアルカリゲネス・エスピー.KS−85株由来クレ
アチンアミジノハイドロラーゼ遺伝子を含む組み換え体
プラスミドpUCE100DNA(特開平8−8925
5号公報記載)を、大腸菌(E.coli)JM109
(pUCE100)(FERM BP−4803)か
ら、例えば、QIAGEN(フナコシ社製)を利用する
ことにより抽出、精製する。なお、本発明において用い
ることのできるベクターDNAとしては、上記プラスミ
ドベクターDNAに限定されることなくそれ以外の、例
えば、バクテリオファージベクターDNA、プラスミド
ベタターDNA等を用いることができる。具体的にはp
UC118(宝酒造社製)等が好ましい。
BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in detail.
The thermostable creatine amidinohydrolase of the present invention,
For example, it can be obtained as follows. First, the isolated alkaligenes sp. Recombinant plasmid pUCE100 DNA containing the creatine amidinohydrolase gene derived from the KS-85 strain (JP-A-8-8925)
No. 5) described in E. coli JM109.
(PUCE100) (FERM BP-4803) is extracted and purified by using, for example, QIAGEN (manufactured by Funakoshi). The vector DNA that can be used in the present invention is not limited to the above-described plasmid vector DNA, but may be other ones such as bacteriophage vector DNA and plasmid beta DNA. Specifically, p
UC118 (manufactured by Takara Shuzo) or the like is preferable.

【0007】次いで、配列番号1に示されるアミノ酸配
列において1もしくは複数のアミノ酸が欠失、置換もし
くは付加されたアミノ酸配列からなり、かつクレアチン
アミジノハイドロラーゼ活性、好ましくは、耐熱性クレ
アチンアミジノハイドロラーゼ活性を有するタンパク質
をコードする耐熱性クレアチンアミジノハイドロラーゼ
遺伝子を得るには、如何なる方法でもよく、例えば、こ
の組み換え体プラスミドDNAに、例えば、ハイドロキ
シルアミン、亜硝酸等の化学変異剤やPCR法を用いて
ランダムに変換する方法等の点変異、市販のキットを利
用する部位特異的な置換または欠失変異を生じさせるた
めの周知技術である部位特定変異誘導法;この組み換え
体プラスミドDNAを選択的に開裂し、次いで選択され
たオリゴヌクレオチドを除去または付加し、連結する方
法;オリゴヌクレオチド変異誘導法等が挙げられる。
[0007] Next, one or more amino acids are deleted, substituted or added in the amino acid sequence shown in SEQ ID NO: 1 and the creatine amidinohydrolase activity, preferably, the heat-resistant creatine amidinohydrolase activity Any method may be used to obtain a thermostable creatine amidinohydrolase gene encoding a protein having, for example, a recombinant mutagenized DNA, for example, using a chemical mutagen such as hydroxylamine or nitrite or a PCR method. Point mutation such as random conversion, site-specific mutagenesis, which is a well-known technique for generating site-specific substitution or deletion mutation using a commercially available kit; selective cleavage of this recombinant plasmid DNA And then the selected oligonucleotides De removing or adding a method for coupling; oligonucleotide mutagenesis method.

【0008】上記処理後の組み換え体DNAを脱塩カラ
ム、QIAGEN(フナコシ社製)等を用いて精製し、
種々の組み換え体DNAを得る。
[0008] The recombinant DNA after the above treatment is purified using a desalting column, QIAGEN (manufactured by Funakoshi) and the like.
Various recombinant DNAs are obtained.

【0009】このようにして得られた種々の組み換え体
DNAを用いて、例えば、大腸菌K12、好ましくは大
腸菌JM109(東洋紡社製)、XL1−Blue〔フ
ナコシ(株)製〕等を形質転換または形質導入し、種々
のクレアチンアミジノハイドロラーゼ遺伝子断片を保有
する組み換え体DNAを含む形質転換体または形質導入
体を得ることができる。
The various recombinant DNAs thus obtained are used to transform or transform E. coli K12, preferably E. coli JM109 (manufactured by Toyobo), XL1-Blue (manufactured by Funakoshi Co., Ltd.), etc. After the introduction, a transformant or a transductant containing a recombinant DNA having various creatine amidinohydrolase gene fragments can be obtained.

【0010】そして、例えば、形質転換体の場合、得ら
れた形質転換体(その中に種々の耐熱性クレアチンアミ
ジノハイドロラーゼ遺伝子を含む組み換え体プラスミド
DNAを含有している。)より、目的の性質(耐熱性及
びKm値の低い)を有する耐熱性クレアチンアミジノハ
イドロラーゼを生産する株を得るには、次のような方法
を用いることができる。
[0010] For example, in the case of a transformant, desired properties are obtained from the obtained transformant (which contains recombinant plasmid DNA containing various thermostable creatine amidinohydrolase genes). The following method can be used to obtain a strain producing thermostable creatine amidinohydrolase having (low heat resistance and low Km value).

【0011】先ず、得られた上記形質転換体を各コロニ
ー毎にTY培地(50μg Ampicilin,lm
M IPTG添加)等で液体培養し、組み換え体プラス
ミドDNAに含まれる種々の耐熱性クレアチンアミジノ
ハイドロラーゼを誘導生産させる。培養後、得られた培
養物に対し超音波破砕を行ない、その粗酵素抽出液に対
し50℃、30分間の熱処理後の残存活性、ラインウエ
ーバー・バークのプロットによるKm値の測定を行な
う。また、各変異株の測定結果に対し、同様にして抽
出、処理、測定した野生型タンパク質と比較を行ない目
的とする形質転換体を選択する。
First, the above-mentioned transformant was used for each colony in a TY medium (50 μg Ampicillin, lm).
(M IPTG addition) and the like to induce various heat-resistant creatine amidinohydrolases contained in the recombinant plasmid DNA. After the culture, the obtained culture is subjected to ultrasonic crushing, and the crude enzyme extract is subjected to measurement of the residual activity after heat treatment at 50 ° C. for 30 minutes and the Km value based on a line weber-Burk plot. In addition, the target transformant is selected by comparing the measurement results of each mutant strain with the extracted, treated, and measured wild-type protein in the same manner.

【0012】上記のようにして得られた耐熱性クレアチ
ンアミジノハイドロラーゼ生産能を有する形質転換体ま
たは形質導入体、好ましくは、エッシェリシア属に属す
る菌株を用いて耐熱性クレアチンアミジノハイドロラー
ゼを生産するには、下記のようにして行なうことができ
る。上記微生物を培養するには、通常の固体培養法で培
養してもよいが、なるべく液体培養法を採用して培養す
るのが好ましい。
A heat-resistant creatine amidinohydrolase-producing transformant or transductant obtained as described above, preferably a strain belonging to the genus Escherichia, is used to produce heat-resistant creatine amidinohydrolase. Can be performed as follows. In order to culture the above microorganism, it may be cultured by a usual solid culture method, but it is preferable to employ a liquid culture method as much as possible.

【0013】また、上記微生物を培養する培地として
は、例えば、酵母エキス、ペプトン、肉エキス、コーン
ステイープリカー、大豆もしくは小麦麹の浸出液等の1
種以上の窒素源に、リン酸二水素カリウム、リン酸水素
二カリウム、硫酸マグネシウム、塩化第2鉄、硫酸第2
鉄もしくは硫酸マンガン等の無機塩類の1種以上を添加
し、更に必要により糖質原料、ビタミン等を適宜添加し
たものが用いられる。
Examples of the medium for culturing the microorganisms include yeast extract, peptone, meat extract, corn steep liquor, leachate of soybean or wheat koji, and the like.
More than one nitrogen source includes potassium dihydrogen phosphate, dipotassium hydrogen phosphate, magnesium sulfate, ferric chloride, and sulfuric acid
One or more inorganic salts such as iron or manganese sulfate are added, and if necessary, saccharide raw materials, vitamins and the like are appropriately added.

【0014】なお、培地の初発pHは、7〜9に調整す
るのが適当である。また培養は、30〜42℃、好まし
くは37℃前後で6〜24時間、通気撹拌深部培養、振
とう培養、静置培養等により実施するのが好ましい。培
養終了後、該培養物より耐熱性クレアチンアミジノハイ
ドロラーゼを採取するには、通常の酵素採取手段を用い
ることができる。
The initial pH of the medium is suitably adjusted to 7-9. The cultivation is preferably carried out at 30 to 42 ° C, preferably around 37 ° C for 6 to 24 hours, by aeration and stirring deep culture, shaking culture, static culture and the like. After completion of the culture, a normal enzyme collecting means can be used to collect the thermostable creatine amidinohydrolase from the culture.

【0015】培養物から、例えば、濾過、遠心分離等の
操作により菌体を分離し、洗菌する。この菌体から耐熱
性クレアチンアミジノハイドロラーゼを採取することが
好ましい。この場合、菌体をそのまま用いることもでき
るが、超音波破砕機、フレンチプレス、ダイナミル等の
種々の破壊手段を用いて菌体を破壊する方法、リゾチー
ムの如き細胞壁溶解酵素を用いて菌体細胞壁を溶解する
方法、トリトンX−100等の界面活性剤を用いて菌体
から酵素を抽出する方法等により、菌体から耐熱性クレ
アチンアミジノハイドロラーゼを採取するのが好まし
い。
The cells are separated from the culture by, for example, filtration, centrifugation, etc., and washed. It is preferable to collect thermostable creatine amidinohydrolase from the cells. In this case, the cells can be used as they are, but a method of destroying the cells using various disrupting means such as an ultrasonic crusher, a French press, and a dynamill, a cell cell wall using a cell wall lysing enzyme such as lysozyme. It is preferable to collect the thermostable creatine amidinohydrolase from the cells by a method of dissolving the enzyme, a method of extracting the enzyme from the cells using a surfactant such as Triton X-100, or the like.

【0016】このようにして得られた粗酵素液から耐熱
性クレアチンアミジノハイドロラーゼを単離するには、
通常の酵素精製に用いられる方法が使用できる。例え
ば、硫安塩析法、有機溶媒沈澱法、イオン交換クロマト
グラフ法、ゲル濾過クロマトグラフ法、吸着クロマトグ
ラフ法、電気泳動法等を適宜組み合わせて行なうのが好
ましい。
To isolate thermostable creatine amidinohydrolase from the thus obtained crude enzyme solution,
A method used for ordinary enzyme purification can be used. For example, it is preferable to carry out an appropriate combination of ammonium sulfate salting out, organic solvent precipitation, ion exchange chromatography, gel filtration chromatography, adsorption chromatography, electrophoresis and the like.

【0017】得られた耐熱性クレアチンアミジノハイド
ロラーゼの理化学的性質は、下記の通りである。 (1)作用 1モルのクレアチンを加水分解し、1モルのザルコシン
及び1モルの尿素を生成する。
The physicochemical properties of the resulting thermostable creatine amidinohydrolase are as follows. (1) Action One mole of creatine is hydrolyzed to produce one mole of sarcosine and one mole of urea.

【0018】(2)基質特異性 クレアチンに基質特異性を有する。(2) Substrate Specificity Creatine has substrate specificity.

【0019】(3)至適pH 緩衝液として、50mM酢酸ナトリウム−酢酸緩衝液
(pH4.0〜5.5)、50mM MES緩衝液(p
H5.5〜6.5)、50mMリン酸緩衝液(pH6.
5〜8.0)、50mM Tris−HCl緩衝液(p
H8.0〜9.0)、50mM CHES緩衝液(pH
9.0〜10.0)及び50mM CAPS緩衝液(p
H10.0〜11.0)を用い、夫々のpHにおいて、
温度37℃で10分間酵素反応を行なった結果、その相
対活性は、図1に示す通りであった。図1より、本酵素
の至適pHは、7.0〜8.0であった。 (4)作用適温の範囲 後述の活性測定法における反応液と同一組成よりなる反
応液を用い、種々の温度にて本酵素の活性測定を行なっ
た結果、図2に示す通りであった。図2より、本酵素の
作用適温の範囲は、45℃付近であった。
(3) 50 mM sodium acetate-acetic acid buffer (pH 4.0-5.5), 50 mM MES buffer (p
H5.5-6.5), 50 mM phosphate buffer (pH 6.5).
5-8.0), 50 mM Tris-HCl buffer (p
H8.0-9.0), 50 mM CHES buffer (pH
9.0-10.0) and 50 mM CAPS buffer (p
H10.0 to 11.0) at each pH
As a result of performing the enzyme reaction at a temperature of 37 ° C. for 10 minutes, the relative activities were as shown in FIG. From FIG. 1, the optimum pH of the present enzyme was 7.0 to 8.0. (4) Range of suitable temperature for action The activity of the present enzyme was measured at various temperatures using a reaction solution having the same composition as the reaction solution in the activity measurement method described later. As a result, the result was as shown in FIG. 2. As shown in FIG. 2, the range of suitable temperature for the action of this enzyme was around 45 ° C.

【0020】(5)安定pH範囲 緩衝液として、50mM酢酸ナトリウム−酢酸緩衝液
(pH4.0〜5.5)、50mM MES緩衝液(p
H5.5〜6.5)、50mMリン酸緩衝液(pH6.
5〜8.0)、50mM Tris−HCl緩衝液(p
H8.0〜9.0)、50mM CHES緩衝液(pH
9.0〜10.0)及び50mM CAPS緩衝液(p
H10.0〜11.0)を用い、pH4.0〜11.0
において25℃で17時間夫々処理した後、本酵素の残
存活性を測定した結果、図3に示す通りであった。図3
より、安定pH範囲は、pH4.0〜11.0であっ
た。 (6)熱安定性 50mM Tris−HCl緩衝液(pH7.5)を用
いて、各温度で30分間処理した場合の熱安定性の結果
は、図4に示す通りであり、本酵素は、53℃付近迄安
定であった。
(5) Stable pH range As a buffer, 50 mM sodium acetate-acetic acid buffer (pH 4.0 to 5.5), 50 mM MES buffer (p
H5.5-6.5), 50 mM phosphate buffer (pH 6.5).
5-8.0), 50 mM Tris-HCl buffer (p
H8.0-9.0), 50 mM CHES buffer (pH
9.0-10.0) and 50 mM CAPS buffer (p
H10.0-11.0) and pH 4.0-11.0.
After treatment at 25 ° C. for 17 hours, the residual activity of the present enzyme was measured, and the results were as shown in FIG. FIG.
Thus, the stable pH range was pH 4.0 to 11.0. (6) Thermostability The results of thermostability when treated with 50 mM Tris-HCl buffer (pH 7.5) at each temperature for 30 minutes are as shown in FIG. It was stable up to around ° C.

【0021】(7)酵素活性測定法 本酵素の活性の測定は、下記条件下で行なった。なお、
1分間に1マイクロモルの尿素を生成する酵素活性を1
単位とする。 (試薬調製) 1液;基質液)クレアチン6.63gを50mMリン酸
緩衝液(pH7.7)500mlに溶解する。 2液;発色液)ρ−ジメチルアミノベンズアルデヒド1
0gを500mlの特級エタノールに溶解し、レジン水
575ml、濃塩酸75mlを混合したものと混合す
る。
(7) Enzyme activity measurement method The activity of the present enzyme was measured under the following conditions. In addition,
Enzyme activity that produces 1 micromole of urea per minute
Unit. (Reagent preparation) 1 solution; substrate solution) 6.63 g of creatine is dissolved in 500 ml of 50 mM phosphate buffer (pH 7.7). 2 liquid; coloring solution) ρ-dimethylaminobenzaldehyde 1
0 g is dissolved in 500 ml of special grade ethanol and mixed with a mixture of 575 ml of resin water and 75 ml of concentrated hydrochloric acid.

【0022】(測定手順) 1)1液 0.9mlを37℃にて5分間プレインキュ
ベーションする。 2)酵素液(1〜2U/ml程度に調整)0.1mlを
混合し、37℃において10分間反応させる。 3)10分間の反応後、上記2液2mlを混合する。 4)2液と混合後、25℃にて20分間放置し、後に4
35nmの吸光度を測定する。(ODsample) 5)ブランク値の測定は、1液0.9mlを37℃にて
10分間インキュベーションした後、上記2液2mlを
混合し、更に酵素液0.1mlを混合、25℃にて20
分間放置し、その後435nmの吸光度を測定すること
によって行なった。(ODblank)
(Measurement procedure) 1) 0.9 ml of 1 solution is preincubated at 37 ° C. for 5 minutes. 2) 0.1 ml of an enzyme solution (adjusted to about 1 to 2 U / ml) is mixed and reacted at 37 ° C. for 10 minutes. 3) After the reaction for 10 minutes, 2 ml of the above two liquids are mixed. 4) After mixing with the two liquids, the mixture was left at 25 ° C. for 20 minutes.
Measure the absorbance at 35 nm. (ODsample) 5) The blank value was measured by incubating 0.9 ml of 1 solution at 37 ° C. for 10 minutes, mixing 2 ml of the above 2 solutions, further mixing 0.1 ml of the enzyme solution, and adding 20 ml at 25 ° C.
This was performed by allowing the mixture to stand for a minute and then measuring the absorbance at 435 nm. (ODblank)

【0023】(活性の計算) U/ml=△OD※×18.06*×希釈倍率 ※(△OD=ODsample−ODblank) (*尿素検量線より算出した係数)(Calculation of activity) U / ml = ΔOD * × 18.06 ** × dilution ratio * (ΔOD = ODsample−ODblank) (* coefficient calculated from urea calibration curve)

【0024】(8)Km値 上記の活性測定法を用い、本酵素のKm値を測定したと
ころ、ラインウエーバー・バークのプロットから、Km
値は、8.6mM(クレアチンに対して)であった。 (9)分子量 92,000(ゲル濾過法)
(8) Km value The Km value of the present enzyme was measured using the above-mentioned activity measurement method.
The value was 8.6 mM (relative to creatine). (9) Molecular weight 92,000 (gel filtration method)

【0025】[0025]

【実施例】以下、本発明を実施例により更に具体的に説
明する。
EXAMPLES Hereinafter, the present invention will be described more specifically with reference to examples.

【0026】(実施例1) (1)組み換え体プラスミドpUCE100DNAの調
製 大腸菌(E.coli)JM109(pUCE100)
(FERM BP−4803)を、TY培地(1%バク
トートリプトン、0.5%ペプトン、0.25%NaC
l)20mlに接種して、37℃で18時間振とう培養
し培養物を得た。この培養物を6000rpmで10分
間遠心分離することにより集菌して菌体を得た。この菌
体よりQIAGEN tip−100を用いて組み換え
体プラスミドpUCE100DNAを抽出して精製し、
組み換え体プラスミドpUCE100DNAを70μg
得た。
(Example 1) (1) Preparation of recombinant plasmid pUCE100 DNA E. coli JM109 (pUCE100)
(FERM BP-4803) in TY medium (1% Bacto Tryptone, 0.5% Peptone, 0.25% NaC)
l) Inoculated into 20 ml and shake-cultured at 37 ° C for 18 hours to obtain a culture. The culture was collected by centrifugation at 6000 rpm for 10 minutes to obtain cells. The recombinant plasmid pUCE100 DNA was extracted from the cells using QIAGEN tip-100 and purified.
70 μg of the recombinant plasmid pUCE100 DNA
Obtained.

【0027】(2)変異操作 上記組み換え体プラスミドDNA100μgの内、2μ
gを用いてXL1−RED(STRATAGENE社
製)(増殖の際、プラスミドの複製にエラーを起こし易
く変異を生じ易い。)をD.M.Morrisonの方
法(Methodin Enzymology,68,
326−331,1979)に従って形質転換し、約1
500の形質転換株を得たその内のコロニー500個を
TY培地20mlに全て植菌し、37℃、18時間振と
う培養した。培養後、この培養物を6000rpmで1
0分間遠心分離することにより集菌して菌体を得た。こ
の菌体よりQIAGEN tip−100(フナコシ社
製)を用いてプラスミドpUCE100を抽出して精製
し、被変異組み換え体プラスミドpUCE100DNA
を70μg得た。このプラスミド5μgを用い、D.
M.Morrisonの方法(Method in E
nzymology,68,326−331,197
9)に従って大腸菌JM109株(東洋紡社製)を形質
転換した結果、約2000個の変異を受けたプラスミド
を保有する形質転換株約2000個を得た。
(2) Mutation operation Of the recombinant plasmid DNA (100 μg), 2 μm
Using XL-RED (manufactured by STRATAGENE) (prone to cause an error in replication of plasmid and cause mutation during propagation) using D. g. M. The method of Morrison (Methodin Enzymology, 68,
326-331, 1979).
500 transformants obtained from 500 transformants were all inoculated into 20 ml of TY medium and cultured with shaking at 37 ° C. for 18 hours. After culturing, the culture is grown at 6000 rpm for 1 hour.
The cells were collected by centrifugation for 0 minutes to obtain cells. The plasmid pUCE100 was extracted and purified from the cells using QIAGEN tip-100 (manufactured by Funakoshi), and the recombinant plasmid pUCE100 DNA to be mutated was extracted.
Was obtained in an amount of 70 μg. Using 5 μg of this plasmid,
M. Morrison's Method (Method in E
nzymology, 68, 326-331, 197
As a result of transforming Escherichia coli JM109 strain (manufactured by Toyobo Co., Ltd.) according to 9), about 2,000 transformed strains having about 2,000 mutated plasmids were obtained.

【0028】(3)耐熱性及び基質との反応性が向上し
た変異株のスクリーニング 先ず、得られた上記形質転換体を各コロニー毎に2ml
のTY培地(50μgAmpicilin,1mM I
PTG添加)で液体培養し、プラスミドに含まれる種々
の耐熱性クレアチンアミジノハイドロラーゼを誘導生産
させた。培養後、得られた培養物に対し超音波破砕を行
ない、その粗酵素抽出液に対し50℃、30分間の熱処
理後の残存活性を測定し、耐熱性が良好であったものに
ついて、ラインウエーバー・バークのプロットによるK
m値の測定を行なった。また、各変異株の測定結果に対
し、同様にして抽出処理し、測定した野生型クレアチン
アミジノハイドロラーゼと比較を行ない目的を満たす変
異株を選択したところ、変異株大腸菌(E.coli)
JM109(pUCE100 B−40)より、耐熱性
クレアチンアミジノハイドロラーゼを得た。大腸菌
(E.coli)JM109(pUCE100 B−4
0)は、工業技術院生命工学工業技術研究所にFERM
P−15971として寄託されている。
(3) Screening of mutant strains having improved heat resistance and reactivity with a substrate First, 2 ml of the obtained transformant was used for each colony.
TY medium (50 μg Ampicillin, 1 mM I
(PTG addition), and various heat-resistant creatine amidinohydrolases contained in the plasmid were induced and produced. After culturing, the obtained culture was subjected to ultrasonic crushing, and the residual activity of the crude enzyme extract after heat treatment at 50 ° C. for 30 minutes was measured.・ K by Bark's plot
The m value was measured. In addition, the measurement results of each mutant were subjected to extraction treatment in the same manner, and compared with the measured wild-type creatine amidinohydrolase, and a mutant satisfying the purpose was selected, and the mutant Escherichia coli (E. coli) was selected.
Thermostable creatine amidinohydrolase was obtained from JM109 (pUCE100 B-40). E. coli JM109 (pUCE100 B-4)
0) is a FERM to the Institute of Biotechnology and Industrial Technology
Deposited as P-15971.

【0029】(実施例2)上記のようにして得られた変
異株大腸菌(E.coli)JM109(pUCE10
0 B−40)を、1mMイソプロピル−β−D−ガラ
クトシドを含むTY培地(1%バクト−トリプトン、
0.5%バクト−イーストエクストラクト、0.5%N
aCl,pH7.5)100mlの分注された坂口フラ
スコで16時間振とう培養したのち、同様に調製した3
0L培養槽中のTY培地20Lに火炎接種した。接種
後、回転数450rpm、通気量20L/min、37
℃にて約20時間培養した。
Example 2 A mutant E. coli JM109 (pUCE10) obtained as described above was used.
0 B-40) in TY medium containing 1 mM isopropyl-β-D-galactoside (1% bacto-tryptone,
0.5% Bacto-yeast extract, 0.5% N
aCl, pH 7.5) After shaking culture in a 100 ml dispensed Sakaguchi flask for 16 hours, 3
A flame was inoculated into 20 L of a TY medium in a 0 L culture tank. After inoculation, the number of rotations was 450 rpm, the air flow was 20 L / min,
C. for about 20 hours.

【0030】培養終了後、培養液20Lからマイクロー
ザー(旭化成社製、PW−303)を用いて菌体を集菌
し、20mMリン酸緩衝液(pH7.5)にて菌体を洗
浄した後、菌体を同緩衝液約10Lに懸濁した。 ステップ1(粗酵素液の調整):上記菌体懸濁液(10
L)に、リゾチーム20g(50mMリン酸緩衝、pH
7.5、100ml)及び0.55M EDTA、pH
8.0、1Lを添加、混合し、30℃で一晩放置した
後、5%プロタミン水溶液(pH8.0)500mlを
撹拌しながら滴下して除核酸処理を行なった。この水溶
液を10mM CAPS−NaOH緩衝液(pH10.
0)(以下緩衝液Aとする)に対して透析した。
After completion of the culture, the cells were collected from 20 L of the culture solution using a Microser (PW-303, manufactured by Asahi Kasei Corporation), and washed with a 20 mM phosphate buffer (pH 7.5). The cells were suspended in about 10 L of the same buffer. Step 1 (adjustment of crude enzyme solution):
L), lysozyme 20 g (50 mM phosphate buffer, pH
7.5, 100 ml) and 0.55 M EDTA, pH
After adding and mixing 8.0 L and leaving the mixture at 30 ° C. overnight, 500 ml of a 5% aqueous protamine solution (pH 8.0) was added dropwise with stirring to remove nucleic acid. This aqueous solution was added to a 10 mM CAPS-NaOH buffer solution (pH 10.
0) (hereinafter referred to as buffer A).

【0031】ステップ2(DEAE−セルロース処
理):透析液(約28L)に、湿重量で約3kgのセル
ロースを添加、混合して、耐熱性クレアチンアミジノハ
イドロラーゼを吸着させた後、5%グリセリン及び0.
05%2−メルカプトエタノール含有緩衝液AにてDE
AE−セルロースを洗浄し、次いで、0.5M KCl
含有緩衝液Aにて耐熱性クレアチンアミジノハイドロラ
ーゼを溶出して限外濃縮した。 ステップ3(DEAE−セファロースCL−4B処
理):濃縮液(約1.0L)に、緩衝液Aで緩衝化され
た湿重量で約1.0kgのDEAE−セファロースCL
−4Bを添加、混合して、耐熱性クレアチンアミジノハ
イドロラーゼを吸着させ0.05M KCl含有 緩衝
液AにてDEAE−セファロースCL−4Bを洗浄し、
次いで、0.1M KCl含有、緩衝液Aにて耐熱性ク
レアチンアミジノハイドロラーゼを溶出して、限外濃縮
した。 ステップ4(セファタリルS−200処理):濃縮液
(約1.0L)をカラムに詰めたセファクリルS−20
0にて分子ふるいを行ない、活性画分(2.2g)を収
集した。活性画分の比活性は、9U/OD280nmで
あった。
Step 2 (DEAE-cellulose treatment): Approximately 3 kg of cellulose by wet weight is added to a dialysate (about 28 L) and mixed to adsorb thermostable creatine amidinohydrolase, and then 5% glycerin and 0.
DE in buffer A containing 05% 2-mercaptoethanol
Wash AE-cellulose, then add 0.5M KCl
The heat-resistant creatine amidinohydrolase was eluted with the contained buffer solution A and ultra-concentrated. Step 3 (DEAE-Sepharose CL-4B treatment): A concentrated solution (about 1.0 L) was added with about 1.0 kg of DEAE-Sepharose CL wet weight buffered with buffer A.
-4B was added and mixed, and the DEAE-Sepharose CL-4B was washed with a buffer A containing 0.05 M KCl and adsorbing thermostable creatine amidinohydrolase,
Next, the heat-resistant creatine amidinohydrolase was eluted with buffer A containing 0.1 M KCl, and ultra-concentrated. Step 4 (Sephataryl S-200 treatment): Sephacryl S-20 in which a concentrated solution (about 1.0 L) was packed in a column
At 0, molecular sieving was performed and the active fraction (2.2 g) was collected. The specific activity of the active fraction was 9 U / OD 280 nm.

【発明の効果】本発明によれば、耐熱性クレアチンアミ
ジノハイドロラーゼが効率よく製造でき、本発明は、産
業上有用である。
According to the present invention, thermostable creatine amidinohydrolase can be efficiently produced, and the present invention is industrially useful.

【0032】[0032]

【配列表】SEQUENCE LISTING 〈110〉KIKKOMAN CORPORATION 〈120〉THERMOSTABLE CREATIN
E AMIDINOHYDROLASE AND PR
OCESS FOR PRODUCING THE S
AME 〈130〉P2035 〈160〉1 〈210〉1 〈211〉404 〈212〉PRT 〈213〉Alcaligenes sp. 〈400〉1
[Sequence List] SEQUENCE LISTING <110> KIKOMAN CORPORATION <120> THERMOSTABLE CREATING
E AMIDINOHYDROLASE AND PR
OCESS FOR PRODUCING THE S
AME <130> P2035 <160> 1 <210> 1 <211> 404 <212> PRT <213> Alcaligenes sp. <400> 1

【図面の簡単な説明】[Brief description of the drawings]

【図1】本酵素の至適pHを示す図。FIG. 1 is a diagram showing the optimum pH of the present enzyme.

【図2】本酵素の作用適温の範囲を示す図。FIG. 2 is a graph showing a suitable temperature range for the action of the present enzyme.

【図3】本酵素の安定pH範囲を示す図。FIG. 3 is a view showing a stable pH range of the present enzyme.

【図4】本酵素の熱安定性を示す図。FIG. 4 shows the thermostability of the present enzyme.

─────────────────────────────────────────────────────
────────────────────────────────────────────────── ───

【手続補正書】[Procedure amendment]

【提出日】平成11年9月7日(1999.9.7)[Submission date] September 7, 1999 (1999.9.7)

【手続補正1】[Procedure amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】0028[Correction target item name] 0028

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【0028】(3)耐熱性及び基質との反応性が向上した
変異株のスクリーニング 先ず、得られた上記形質転換体を各コロニー毎に2mlのT
Y培地(50μg Ampicilin,1mM IPTG添加)で液体培養
し、プラスミドに含まれる種々の耐熱性クレアチンアミ
ジノハイドロラーゼを誘導生産させた。培養後、得られ
た培養物に対し超音波破砕を行ない、その粗酵素抽出液
に対し50℃、30分間の熱処理後の残存活性を測定し、耐
熱性が良好であったものについて、ラインウエーバー・
バークのプロットによるKm値の測定を行なった。また、
各変異株の測定結果に対し、同様にして抽出処理し、測
定した野生型クレアチンアミジノハイドロラーゼと比較
を行ない目的を満たす変異株を選択したところ、変異株
大腸菌(E.coli)JM109(pUCE100 B-40)より、耐熱性クレ
アチンアミジノハイドロラーゼを得た。大腸菌(E.coli)
JM109(pUCE100 B-40)は、工業技術院生命工学工業技術
研究所FERM BP-6867に(FERM P-15971号より移管)とし
(3) Screening of mutant strains having improved heat resistance and reactivity with a substrate First, the obtained transformant was transformed with 2 ml of T
Liquid culture was performed in a Y medium (50 μg Ampicilin, supplemented with 1 mM IPTG) to induce various heat-resistant creatine amidinohydrolases contained in the plasmid. After the culture, the obtained culture was subjected to ultrasonic crushing, and the residual activity of the crude enzyme extract after heat treatment at 50 ° C. for 30 minutes was measured.・
Km values were measured by Bark's plot. Also,
For the measurement results of each mutant strain, the same extraction treatment was performed, and a mutant strain satisfying the purpose was selected by comparing with the measured wild-type creatine amidinohydrolase, and the mutant E. coli (E. coli) JM109 (pUCE100 B -40), a thermostable creatine amidinohydrolase was obtained. E. coli
JM109 (pUCE100 B-40) is transferred to FERM BP-6867 (Biotech) from FERM P-15971.

【書類名】 受託番号変更届[Document name] Notification of change of accession number

【提出日】 平成11年9月10日(19
99.9.10)
[Submission date] September 10, 1999 (19
99.9.10.)

【旧寄託機関の名称】 通商産業省工業技術院生命
工学工業技術研究所
[Name of former depositary institution] Institute of Biotechnology and Industrial Technology, Ministry of International Trade and Industry

【旧受託番号】 FERM P−15971[Old Accession Number] FERM P-15971

【新寄託機関の名称】 通商産業省工業技術院生命
工学工業技術研究所
[Name of the new deposited organization] Institute of Biotechnology and Industrial Technology, Ministry of International Trade and Industry

【新受託番号】 FERM BP−6867[New accession number] FERM BP-6867

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) C12R 1:19) Fターム(参考) 4B050 CC01 CC03 DD02 LL03 4B065 AA26X AA26Y AC02 BA02 BA16 CA31 CA46 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI Theme coat ゛ (Reference) C12R 1:19) F-term (Reference) 4B050 CC01 CC03 DD02 LL03 4B065 AA26X AA26Y AC02 BA02 BA16 CA31 CA46

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 下記の理化学的性質を有する耐熱性クレ
アチンアミジノハイドロラーゼ。 (a)作用;1モルのクレアチンを加水分解し、1モル
のザルコシン及び1モルの尿素を生成する。 (b)基質特異性;クレアチンに基質特異性を有する。 (c)至適pH;7.0〜8.0 (d)安定pH範囲;4.0〜11.0 (e)作用適温の範囲;45℃付近 (f)熱安定性;53℃ (g)分子量;92,000(ゲル濾過法)
1. A thermostable creatine amidinohydrolase having the following physicochemical properties. (A) action; hydrolyze 1 mole of creatine to produce 1 mole of sarcosine and 1 mole of urea. (B) substrate specificity; creatine has substrate specificity. (C) optimum pH; 7.0 to 8.0 (d) stable pH range; 4.0 to 11.0 (e) range of suitable temperature for operation; around 45 ° C (f) thermal stability; 53 ° C (g ) Molecular weight: 92,000 (gel filtration method)
【請求項2】 請求項1記載の理化学的性質を有する耐
熱性クレアチンアミジノハイドロラーゼ生産能を有する
微生物を培養し、その培養物から耐熱性クレアチンアミ
ジノハイドロラーゼを採取することを特徴とする耐熱性
クレアチンアミジノハイドロラーゼの製造法。
2. A heat-resistant creatine amidinohydrolase having physicochemical properties according to claim 1, wherein the microorganism is capable of producing heat-resistant creatine amidinohydrolase, and the heat-resistant creatine amidinohydrolase is collected from the culture. A method for producing creatine amidinohydrolase.
JP03335999A 1999-01-01 1999-01-01 Thermostable creatine amidinohydrolase and process for producing the same Expired - Lifetime JP3773160B2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP03335999A JP3773160B2 (en) 1999-01-01 1999-01-01 Thermostable creatine amidinohydrolase and process for producing the same
US09/869,280 US6821766B1 (en) 1999-01-01 1999-12-28 Thermostable creatine amidinohydrolase and process for producing the same
EP99961487A EP1142994B1 (en) 1999-01-01 1999-12-28 Thermostable creatine amidinohydrolase and process for producing the same
DE69936880T DE69936880T2 (en) 1999-01-01 1999-12-28 Heat Stable CREATINAMIDINE HYDROLASE AND METHOD FOR THE PRODUCTION THEREOF
PCT/JP1999/007424 WO2000040708A1 (en) 1999-01-01 1999-12-28 Thermostable creatine amidinohydrolase and process for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP03335999A JP3773160B2 (en) 1999-01-01 1999-01-01 Thermostable creatine amidinohydrolase and process for producing the same

Publications (2)

Publication Number Publication Date
JP2000201675A true JP2000201675A (en) 2000-07-25
JP3773160B2 JP3773160B2 (en) 2006-05-10

Family

ID=12384401

Family Applications (1)

Application Number Title Priority Date Filing Date
JP03335999A Expired - Lifetime JP3773160B2 (en) 1999-01-01 1999-01-01 Thermostable creatine amidinohydrolase and process for producing the same

Country Status (5)

Country Link
US (1) US6821766B1 (en)
EP (1) EP1142994B1 (en)
JP (1) JP3773160B2 (en)
DE (1) DE69936880T2 (en)
WO (1) WO2000040708A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7603685B2 (en) 1998-11-03 2009-10-13 United Video Properties, Inc. Program guide system with combination category search
US8786702B2 (en) 2009-08-31 2014-07-22 Behavioral Recognition Systems, Inc. Visualizing and updating long-term memory percepts in a video surveillance system

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2122294C3 (en) * 1971-05-05 1979-08-16 Boehringer Mannheim Gmbh, 6800 Mannheim Process for the production of creatinine amidohydrolase
US4039384A (en) 1975-04-05 1977-08-02 Noda Institute For Scientific Research Creatinine amidohydrolase and creatine amidinohydrolase and process for producing them
JPH0657148B2 (en) * 1985-10-18 1994-08-03 小林製薬株式会社 Method for producing creatine amidino-lolase
DE3803175A1 (en) * 1987-05-12 1988-11-24 Boehringer Mannheim Gmbh STABLE CREATINAMIDINOHYDROLASE MUTANTS
CA1311179C (en) 1987-05-14 1992-12-08 Richard Linn Detwiler Element and method for determination of creatinine or creatine
JP2788174B2 (en) * 1993-12-17 1998-08-20 キッコーマン株式会社 Novel creatine amidinohydrolase and method for producing the same
JP3325128B2 (en) * 1994-09-29 2002-09-17 キッコーマン株式会社 Novel creatine amidinohydrolase gene, novel recombinant DNA and method for producing creatine amidinohydrolase
JP3075390B2 (en) 1996-02-13 2000-08-14 東洋紡績株式会社 Novel creatine amidinohydrolase, its production method and its use
JP3422197B2 (en) * 1996-12-17 2003-06-30 東洋紡績株式会社 Stable creatine amidinohydrolase
JP2000157279A (en) * 1998-11-25 2000-06-13 Kikkoman Corp Creatineamidinohydrolase and its production

Also Published As

Publication number Publication date
JP3773160B2 (en) 2006-05-10
EP1142994A1 (en) 2001-10-10
WO2000040708A1 (en) 2000-07-13
DE69936880T2 (en) 2008-05-08
US6821766B1 (en) 2004-11-23
DE69936880D1 (en) 2007-09-27
EP1142994A4 (en) 2002-11-20
EP1142994B1 (en) 2007-08-15

Similar Documents

Publication Publication Date Title
JP4199422B2 (en) Polypeptide
JP4815219B2 (en) DNA containing an alkalophilic cyclodextran synthase gene, recombinant DNA, and method for producing an alkalophilic cyclodextran synthase
CA2045839C (en) Cloned n-methylhydantoinase
JP4133326B2 (en) Novel fructosyl amino acid oxidase
JP2000201675A (en) Heat-resistant creatine amidinohydrolase and its production
JP4371312B2 (en) Modified sarcosine oxidase, gene thereof, recombinant DNA and method for producing modified sarcosine oxidase
JP2000157279A (en) Creatineamidinohydrolase and its production
JP2005168487A (en) Modified sacrosine oxidase, modified sacrosine oxidase gene, and method for producing the modified sacrosine oxidase
Niu et al. Construction of a highly thermostable 1, 3-1, 4-β-glucanase by combinational mutagenesis and its potential application in the brewing industry
JP2000175685A (en) Sarcosineoxidase and its production
JP3325128B2 (en) Novel creatine amidinohydrolase gene, novel recombinant DNA and method for producing creatine amidinohydrolase
JP5115708B2 (en) Novel hydrogen peroxide-generating NADH oxidase and DNA encoding the same
JP4372986B2 (en) Alkaline pullulanase
JP3587959B2 (en) Modified pyranose oxidase, modified pyranose oxidase gene, novel recombinant DNA and method for producing modified pyranose oxidase
JP3463951B2 (en) Thermostable pyroglutamyl peptidase and its gene
JP2003079386A (en) New fructosyl amino acid oxidase
JP4151892B2 (en) D-amino acid oxidase with excellent heat stability, its gene, recombinant DNA, and method for producing D-amino acid oxidase with excellent heat stability
CN111440807A (en) Shewanella WP3 mutant strain with high yield of low-temperature catalase as well as construction method and application thereof
JP4233306B2 (en) Thermostable cordobiose phosphorylase
CN116590254A (en) DNA polymerase mutant and construction method and application thereof
CN113999827A (en) Leucine dehydrogenase mutant and preparation method and application thereof
CN113528487A (en) Method for improving heat stability of xylanase through iterative saturation mutation
CN115786308A (en) Method for improving heat stability of dextranase and mutant
US20060166313A1 (en) Novel glycero kinase, gene thereof and process for producing the glycerol kinase by using the gene
JP2004121234A (en) New glycerol kinase, gene of the same and method for producing the glycerol kinase by using the gene

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20051220

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060117

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20060207

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20060210

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090224

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100224

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110224

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110224

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120224

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120224

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130224

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140224

Year of fee payment: 8

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term